Anika Therapeutics Inc.

Contributing Author

Recent Articles by Anika Therapeutics Inc.

Feb-26	Anika Reports Fourth Quarter and Full Year 2025 Financial Results ANIK +16.91% GlobeNewswire
Feb-18	Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference ANIK GlobeNewswire
Feb-12	Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026 ANIK GlobeNewswire
Jan-08	Anika Therapeutics Announces Leadership Transition ANIK GlobeNewswire
Nov-05	Anika Reports Third Quarter 2025 Financial Results ANIK GlobeNewswire
Nov-05	Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study ANIK GlobeNewswire
Oct-23	Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025 ANIK GlobeNewswire
Sep-05	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ANIK GlobeNewswire
Jul-30	Anika Reports Second Quarter 2025 Financial Results ANIK -27.42% GlobeNewswire
Jul-30	Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast Cartilage Repair Scaffold and Provides Program Update ANIK -27.42% GlobeNewswire
Jul-16	Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025 ANIK GlobeNewswire
Jul-03	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ANIK GlobeNewswire
Jun-05	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ANIK GlobeNewswire
May-12	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ANIK GlobeNewswire
May-09	Anika Reports First Quarter 2025 Financial Results ANIK -21.03% GlobeNewswire
May-07	Anika to Participate in the Sidoti Virtual Investor Conference ANIK GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)